Nu Skin Enterprises, Inc. (NYSE:NUS) has earned a consensus recommendation of “Hold” from the nine brokerages that are covering the firm. Two investment analysts have rated the stock with a sell recommendation, three have given a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $58.43.
Several analysts have issued reports on the company. Zacks Investment Research raised Nu Skin Enterprises from a “sell” rating to a “hold” rating in a research note on Saturday, February 25th. Deutsche Bank AG reaffirmed a “buy” rating and issued a $63.00 target price on shares of Nu Skin Enterprises in a research report on Sunday, February 19th. Finally, Jefferies Group LLC set a $52.00 target price on Nu Skin Enterprises and gave the company a “hold” rating in a research report on Friday, February 17th.
In other news, General Counsel D Matthew Dorny sold 8,000 shares of the business’s stock in a transaction that occurred on Monday, April 3rd. The stock was sold at an average price of $55.30, for a total transaction of $442,400.00. Following the completion of the sale, the general counsel now owns 53,730 shares in the company, valued at $2,971,269. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Ryan S. Napierski sold 8,400 shares of the business’s stock in a transaction that occurred on Thursday, February 16th. The stock was sold at an average price of $55.00, for a total value of $462,000.00. Following the sale, the insider now owns 48,905 shares of the company’s stock, valued at approximately $2,689,775. The disclosure for this sale can be found here. In the last three months, insiders have sold 32,400 shares of company stock worth $1,704,400. Company insiders own 4.60% of the company’s stock.
Several large investors have recently modified their holdings of NUS. Creative Planning boosted its stake in shares of Nu Skin Enterprises by 38.5% in the first quarter. Creative Planning now owns 1,800 shares of the company’s stock worth $100,000 after buying an additional 500 shares in the last quarter. Solaris Asset Management LLC bought a new stake in shares of Nu Skin Enterprises during the third quarter valued at about $138,000. Catalyst Capital Advisors LLC bought a new stake in shares of Nu Skin Enterprises during the third quarter valued at about $143,000. Independent Portfolio Consultants Inc. bought a new stake in shares of Nu Skin Enterprises during the third quarter valued at about $157,000. Finally, Tower Research Capital LLC TRC bought a new stake in shares of Nu Skin Enterprises during the third quarter valued at about $164,000. Institutional investors own 78.88% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This article was first published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this article on another website, it was stolen and reposted in violation of United States & international copyright legislation. The correct version of this article can be read at https://www.chaffeybreeze.com/2017/04/21/brokerages-set-nu-skin-enterprises-inc-nus-target-price-at-58-43-updated-updated.html.
Nu Skin Enterprises (NYSE:NUS) traded up 0.13% during midday trading on Monday, reaching $55.43. The company’s stock had a trading volume of 255,974 shares. The firm has a market capitalization of $2.91 billion, a PE ratio of 21.74 and a beta of 1.66. The stock has a 50 day moving average of $53.07 and a 200 day moving average of $53.83. Nu Skin Enterprises has a 52 week low of $37.09 and a 52 week high of $66.04.
Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings results on Thursday, February 16th. The company reported $0.79 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.80 by $0.01. Nu Skin Enterprises had a net margin of 6.26% and a return on equity of 20.06%. The firm earned $531.30 million during the quarter, compared to analyst estimates of $553.83 million. During the same period in the prior year, the business earned $0.62 EPS. The business’s revenue for the quarter was down 7.1% compared to the same quarter last year. On average, equities research analysts predict that Nu Skin Enterprises will post $3.16 earnings per share for the current fiscal year.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.
Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.